Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,511Revenue $M71.9Net Margin (%)358Altman Z-Score6.3
Enterprise Value $M2,516EPS $12.0Operating Margin %38.0Piotroski F-Score7
P/E(ttm)10.1Beneish M-Score-0.6Pre-tax Margin (%)49.1Higher ROA y-yY
Price/Book7.910-y EBITDA Growth Rate %--Quick Ratio10.3Cash flow > EarningsN
Price/Sales35.65-y EBITDA Growth Rate %--Current Ratio10.4Lower Leverage y-yY
Price/Free Cash Flow93.7y-y EBITDA Growth Rate %35.6ROA % (ttm)68.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)177Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M20.8ROIC % (ttm)176Gross Margin Increase y-yY

Gurus Latest Trades with LGND

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LGNDKen Fisher 2015-12-31 Reduce$85.69 - $111.85
($99.19)
$ 120.8722%Reduce -0.14%70,583
LGNDKen Fisher 2015-09-30 Reduce$82.1 - $111.25
($97.26)
$ 120.8724%Reduce -12.31%70,683
LGNDKen Fisher 2015-06-30 Reduce$75.67 - $100.9
($87.3)
$ 120.8738%Reduce -1.59%80,608
LGNDJoel Greenblatt 2015-03-31 Sold Out -0.0016%$51.54 - $77.11
($61.42)
$ 120.8797%Sold Out0
LGNDJoel Greenblatt 2014-12-31 Reduce-0.26%$42.36 - $57.96
($52.25)
$ 120.87131%Reduce -99.32%3,766
LGNDKen Fisher 2014-12-31 Add0.01%$42.36 - $57.96
($52.23)
$ 120.87131%Add 132.31%81,908
LGNDJoel Greenblatt 2014-09-30 Add0.23%$46.99 - $64.52
($53.04)
$ 120.87128%Add 894.83%552,053
LGNDJoel Greenblatt 2014-06-30 Buy 0.04%$59.74 - $70.19
($65.09)
$ 120.8786%New holding55,492
LGNDKen Fisher 2014-06-30 Buy $59.74 - $70.19
($65.09)
$ 120.8786%New holding36,908
LGNDJoel Greenblatt 2014-03-31 Sold Out -0.02%$51.52 - $79.58
($66.37)
$ 120.8782%Sold Out0
LGNDJoel Greenblatt 2013-12-31 Add0.01%$44.86 - $57.95
($52.33)
$ 120.87131%Add 124.95%13,803
LGNDJoel Greenblatt 2013-09-30 Buy 0.01%$38.69 - $49.66
($45.21)
$ 120.87167%New holding6,136
LGNDGeorge Soros 2011-09-30 Sold Out -0.0017%$10.89 - $15.95
($13.18)
$ 120.87817%Sold Out0
LGNDGeorge Soros 2011-06-30 Buy $9.56 - $12.02
($10.55)
$ 120.871046%New holding10,000
LGNDGeorge Soros 2009-12-31 Sold Out $9.96 - $14.16
($12.16)
$ 120.87894%Sold Out0
LGNDGeorge Soros 2009-09-30 Buy $13.74 - $18.9
($16.15)
$ 120.87648%New holding4,483
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LGND is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LGND: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KOZARICH JOHN WDirector 2016-04-06Sell5,000$1155.1view
FOEHR MATTHEW WPresident and COO 2016-03-17Sell6,400$96.724.99view
Aryeh JasonDirector 2016-03-08Sell6,129$101.1819.46view
HIGGINS JOHN LCEO 2016-03-07Sell10,833$102.4717.96view
KOZARICH JOHN WDirector 2016-01-20Sell1,666$94.9427.31view
Aryeh JasonDirector 2015-11-11Sell3,000$101.4919.1view
Herman Melanie JDirector of Accounting 2015-11-11Sell7,719$10119.67view
KNOTT DAVID MDirector 2015-08-17Sell4,000$95.9825.93view
KNOTT DAVID MDirector 2015-08-13Sell49,800$96.2625.57view
KNOTT DAVID MDirector 2015-08-07Sell200$99.0222.07view

Quarterly/Annual Reports about LGND:

News about LGND:

Articles On GuruFocus.com
RS Investment Increases Holdings in Ulta Salon, Noble Energy and Fortune Brands Dec 23 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Dan Loeb Sees Opportunity in Latest Activist Target Baxter International Aug 06 2015 
Ligand Pharmaceuticals - Severe competitive threat to key royalty program and “going concern” ri Jun 19 2014 
5 Hot Stocks to Consider Now Mar 30 2012 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) May 05 2010 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 09 2009 
Ligand Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2009 

More From Other Websites
Ligand Pharma Adds Tech, Grows On Partners’ Success Apr 29 2016
Ligand Announces First Quarter 2016 Earnings Reporting Date and Participation in Four Upcoming... Apr 22 2016
Ligand Announces First Quarter 2016 Earnings Reporting Date and Participation in Four Upcoming... Apr 22 2016
Spectrum Pharma Jumps on FDA Orphan Designation Apr 20 2016
VKTX: Positive Phase 1b Data Presented for VK2809 in Hypercholestermic Patients; Recent M&A Activity... Apr 15 2016
Ionis Pharmaceuticals: Valuation Compared to Its Peers Apr 14 2016
Will Ligand Pharmaceuticals (LGND) Continue to Surge Higher? Apr 08 2016
Revolade® Approved in EU as First in Class Therapy for Children Aged 1 Year and Above with Chronic... Apr 07 2016
Ligand Enters Into OmniAb® Platform License Agreement With ABBA Therapeutics Mar 28 2016
Ligand Enters Into OmniAb® Platform License Agreement With ABBA Therapeutics Mar 28 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits Mar 22 2016
Gilead and 4 Other Buy Stocks in the Biotech Industry Mar 22 2016
5 Big-Name Medical Stocks Show Notable Chart Action Mar 15 2016
Valeant Crashes To 4-Year Low; Eli Lilly Hits 1-Year Low Mar 15 2016
Ligand Partner Spectrum Pharmaceuticals Receives FDA Approval of EVOMELA™ (melphalan) for... Mar 15 2016
VKTX: Phase 2 Clinical Trial of VK2809 in Hypercholesterolemia to Initiate Mid-2016… Mar 11 2016
Coverage initiated on Ligand Pharma by Sidoti Mar 11 2016
LIGAND PHARMACEUTICALS INC Financials Mar 03 2016
LIGAND PHARMACEUTICALS INC Files SEC form 8-K/A, Financial Statements and Exhibits Mar 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)